Leo Pharma

From Wikipedia, the free encyclopedia
LEO Pharma A/S
TypeAktieselskab
IndustryPharmaceutical industry
Founded1908; 113 years ago (1908)
FounderAugust Kongsted and Anton Antons
HeadquartersBallerup, Copenhagen, Denmark
Area served
Worldwide
Key people
Catherine Mazzacco (CEO)
ProductsPrescription drugs for dermatology, bone remodeling thrombosis and coagulation
RevenueIncrease DKK 7.973 billion (2014)[1]
Increase DDK 1.5 billion (2014)
Total assetsDecrease DDK 31.627 billion (2014)[1]
Number of employees
Decrease 4,712 (2014)[1]
WebsiteHome Page
Footnotes / references
Wholly owned by a foundation (nonprofit)

LEO Pharma A/S is a multinational Danish pharmaceutical company, founded in 1908, with a presence in about 100 countries. Its headquarters are in Ballerup, near Copenhagen[2] The company is 100% integrated into a private foundation owned by the LEO Foundation.[3] Leo Pharma develops and markets products for dermatology, bone remodeling thrombosis and coagulation.[4] In 1945 it was the first producer of penicillin outside the US and UK.

History[]

Formation & the 20th Century[]

In 1908, pharmacists August Kongsted and Anton Antons bought the LEO Pharmacy in Copenhagen, Denmark. With the purchase, they established 'Københavns Løveapoteks kemiske Fabrik', today known as LEO Pharma. LEO Pharma celebrated its centennial in 2008. Flags bearing the LEO logo were flying in every country where LEO products are available, more than a hundred flags in total. Today, LEO Pharma has an ever growing pipeline with over 4,800 specialists focusing on dermatology and thrombosis.

  • 1912 – The company launched its own Aspirin headache tablet
  • 1917 – The company exported Denmarks first drug, Digisolvin
  • 1940 – The company launched its own heparin product.
  • 1958-08-13 - Patent filed for bendrofluazide.[5]
  • 1962 – The company launched Fucidin to be used to treat staphylococcus infections

21st Century & onwards[]

In 2015, the company announced it would acquire Astellas Pharmas dermatology business for $725 million.[6]

In 2018, the company acquired Bayer's dermatology unit for an undisclosed amount.[7]

References[]

  1. ^ Jump up to: a b c http://www.leo-pharma.com/Files/Filer/LEO_corporate_downloads/LEO_Pharma_Annual_Report_2014_FINAL_Web.pdf
  2. ^ Leo Pharma A/S published list of products Archived 2013-12-02 at the Wayback Machine
  3. ^ "About us - LEO Pharma". leo-pharma.com. Archived from the original on 2015-02-26. Retrieved 2013-11-06.
  4. ^ Highbeam news clipping service, UK
  5. ^ GB 863474 
  6. ^ "LEO Pharma Buys Astellas' Dermatology Business for $725M". GEN.
  7. ^ "Leo Pharma Acquires Bayer's Dermatology Unit". PharmaPhorum.


Stub icon

This pharmacology-related article is a stub. You can help Wikipedia by .

  • v
  • t
Retrieved from ""